24 November 2023

Würth Group and Würth Foundation donate 50 million euros to advance cancer research initiatives at the Champalimaud Foundation

This donation was officially formalised on November 23rd and was announced by Dr. Leonor Beleza, during the latest annual meeting of the Board of Trustees of the Champalimaud Foundation. The announcement took place in the presence of all board members, including Queen Sofia of Spain.

The funding provided by the Würth Group and the non-profit Würth Foundation is intended to support research into pancreatic cancer - a type of malignancy that persists as one of the most lethal, yet remains among the least explored.

Curso Prático Watch & Wait

O Curso terá lugar no dia 15 de dezembro, na Fundação Champalimaud, e oferecerá uma visão detalhada e atualizada sobre esta abordagem. Embora relevante para outras especialidades, este evento destina-se especialmente a médicos das áreas da Cirurgia, Oncologia Médica, Radiologia, Radioncologia e Gastrenterologia.

21 Nov. 2023

Graduate Studies Office Coordinator - Ref. "GSC NOV 23"

Research
Application Starts: 21 Nov. 2023
Application Ends: 31 Dec. 2023

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Graduate Studies Office Coordinator to join our team at the Champalimaud Research Programme. Since the beginning, Champalimaud Research has regarded educating future scientists as one of its main objectives. To this end, the CR has been dedicating considerable efforts to the development and implementation of outstanding educational programmes, including world-class Ph.D.

20 November 2023

Our cerebellar nuclei turn out to be more important than initially thought

If a teacup is steaming, you’ll wait a bit longer before drinking from it. And if your fingers get caught in the door, you'll be more careful next time. These are forms of associative learning, where a positive or negative experience leads to learning behavior. We know that our cerebellum is important in this form of learning. But how exactly does this work?

16 November 2023

United Front in the Battle Against Pancreatic Cancer

A Global Spotlight on a Silent Threat

The exponential rise in pancreatic cancer cases, particularly in industrialised nations, has prompted these leading research centres to join forces. With pancreatic cancer poised to become the second leading cause of cancer death in Europe and the USA within the next two decades, these institutions are emphasising the urgent need for enhanced public awareness about the disease.

15 November 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 9

On November 16th, World Pancreatic Cancer Day aims to raise awareness of this deadly disease, with the ultimate goal of improving survival rates and reducing the risks of pancreatic cancer globally.

02 November 2023

Audio Interview with Gonçalo Cotovio on Lesional OCD using TMS

In this audio interview, Gonçalo explains how this grant will fund ongoing work on Lesional Obsessive Compulsive Disorder (OCD) that is being developed in collaboration with several members of the Neuropsychiatry Unit. The proposal is to use the results from this work to test a new treatment for OCD through transcranial magnetic stimulation (TMS), which will include the Neuropsychiatry Unit’s first clinical trial using therapeutic TMS.
 

Listen to the full audio recording to find out more!

03 November 2023

Check Up #19 - Cancer immunotherapy

Cancer immunotherapy is any treatment that uses our own immune system to fight cancer. There are several types of immunotherapy, some of which are already being used routinely, and others still mostly experimental. They are generally a second line of treatment, following chemotherapy, radiotherapy or surgery. 

02 November 2023

Champalimaud Foundation launches screening for professionals exposed to asbestos

The new programme aims to increase the detection of MPM, focusing on workers at asbestos cement factories, in Portugal, who have been exposed to asbestos since the 1960’s, and covering a total of around 200 people who have already been identified by SOS Amianto.
 

Subscribe to People
Loading
Please wait...